ICUI

SEC source: 0001669639-26-000004 · edgardoc.xml · nonDerivative · entry 4

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,604

F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.775 to $171.69, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001669639-26-000004 · edgardoc.xml · nonDerivative · entry 3

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,296

F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.5 to $169.665, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001669639-26-000004 · edgardoc.xml · nonDerivative · entry 2

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,020

F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.21 to $169.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001669639-26-000004 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,258

F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.20 to $168.145, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001804831-26-000006 · edgardoc.xml · nonDerivative · entry 1

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,062

F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.

F2 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001804831-26-000005 · edgardoc.xml · nonDerivative · entry 4

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,443

F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.77 to $174.08, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001804831-26-000005 · edgardoc.xml · nonDerivative · entry 3

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,556

F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.69 to $173.765, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001804831-26-000005 · edgardoc.xml · nonDerivative · entry 2

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,124

F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.625 to $172.6, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001804831-26-000005 · edgardoc.xml · nonDerivative · entry 1

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,038

F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.57 to $171.495, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001698998-26-000004 · edgardoc.xml · nonDerivative · entry 1

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,062

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0002013412-26-000003 · edgardoc.xml · nonDerivative · entry 1

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,076

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001727477-26-000003 · edgardoc.xml · nonDerivative · entry 1

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,377

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.85 to $183.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001217439-26-000002 · edgardoc.xml · nonDerivative · entry 1

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,871

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.4808 to $182.5701, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001698998-26-000003 · primary_doc.xml · nonDerivative · entry 1

Woolson Daniel · CIK 0001698998 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,479

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.03 to $132.33, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001669639-26-000003 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,460

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001531738-26-000001 · primary_doc.xml · derivative · entry 3

KENNEDY KOLLEEN T · CIK 0001531738 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,475

Underlying: Common Stock · 1,475 shares

Expires 2027-05-13

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001531738-26-000001 · primary_doc.xml · derivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,254 shares

Expires 2026-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001531738-26-000001 · primary_doc.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,539

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for Restricted Stock Units.

SEC source: 0001871884-26-000001 · primary_doc.xml · derivative · entry 3

Hernandez Laurie · CIK 0001871884 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,475

Underlying: Common Stock · 1,475 shares

Expires 2027-05-13

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following stockholder meeting, whichever occurs first.

SEC source: 0001871884-26-000001 · primary_doc.xml · derivative · entry 2

Hernandez Laurie · CIK 0001871884 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,254 shares

Expires 2026-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following stockholder meeting, whichever occurs first.

SEC source: 0001871884-26-000001 · primary_doc.xml · nonDerivative · entry 1

Hernandez Laurie · CIK 0001871884 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

SEC source: 0001217439-26-000001 · primary_doc.xml · derivative · entry 3

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,475

Underlying: Common Stock · 1,475 shares

Expires 2027-05-13

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001217439-26-000001 · primary_doc.xml · derivative · entry 2

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,254 shares

Expires 2026-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001217439-26-000001 · primary_doc.xml · nonDerivative · entry 1

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,249

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

SEC source: 0001534342-26-000008 · primary_doc.xml · derivative · entry 3

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,475

Underlying: Common Stock · 1,475 shares

Expires 2027-05-13

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001534342-26-000008 · primary_doc.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,254 shares

Expires 2027-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001534342-26-000008 · primary_doc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,004

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001645866-26-000001 · primary_doc.xml · derivative · entry 6

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,475

Underlying: Common Stock · 1,475 shares

Expires 2027-05-13

F2 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: These awards vest on the anniversary date of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001645866-26-000001 · primary_doc.xml · derivative · entry 5

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,254 shares

Expires 2026-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: These awards vest on the anniversary date of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001645866-26-000001 · primary_doc.xml · nonDerivative · entry 3

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,214

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These securities are Restricted Stock Units.

SEC source: 0001305975-26-000004 · edgardoc.xml · derivative · entry 3

Hoffmeister David F · CIK 0001305975 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,475

Underlying: Common Stock · 1,475 shares

Expires 2027-05-13

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001305975-26-000004 · edgardoc.xml · derivative · entry 2

Hoffmeister David F · CIK 0001305975 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,254 shares

Expires 2026-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001305975-26-000004 · edgardoc.xml · nonDerivative · entry 1

Hoffmeister David F · CIK 0001305975 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,004

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001645866-26-000001 · primary_doc.xml · derivative · entry 4

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,424 shares

Expires 2026-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001645866-26-000001 · primary_doc.xml · nonDerivative · entry 2

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,960

F1 · price: All shares sold were at the exact price disclosed.

SEC source: 0001645866-26-000001 · primary_doc.xml · nonDerivative · entry 1

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,384

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001534342-26-000007 · primary_doc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,046

F1 · kind: Represents transfer of shares of common stock by the reporting person pursuant to a domestic relations order. The reporting person no longer has a reportable beneficial interest in the shares transferred.

F1 · shares: Represents transfer of shares of common stock by the reporting person pursuant to a domestic relations order. The reporting person no longer has a reportable beneficial interest in the shares transferred.

SEC source: 0001698998-26-000002 · edgardoc.xml · derivative · entry 3

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,924 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F3 · derivative.exercise_date: These PRSUs were granted on May 17, 2023. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 15 of the first, second, and third year following the year of grant.

SEC source: 0001698998-26-000002 · edgardoc.xml · nonDerivative · entry 2

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,602

SEC source: 0001698998-26-000002 · edgardoc.xml · nonDerivative · entry 1

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,897

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

SEC source: 0001727477-26-000002 · edgardoc.xml · derivative · entry 6

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,400 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F5 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F2 · shares: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.

SEC source: 0001727477-26-000002 · edgardoc.xml · derivative · entry 5

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,248 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: These securities are Restricted Stock Units.

F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

SEC source: 0001727477-26-000002 · edgardoc.xml · nonDerivative · entry 4

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,306

SEC source: 0001727477-26-000002 · edgardoc.xml · nonDerivative · entry 3

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,101

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: These securities are Restricted Stock Units.

SEC source: 0001727477-26-000002 · edgardoc.xml · nonDerivative · entry 2

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,853

SEC source: 0001727477-26-000002 · edgardoc.xml · nonDerivative · entry 1

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,154

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F2 · shares: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.

SEC source: 0001410442-26-000002 · edgardoc.xml · derivative · entry 7

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,100 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F5 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F2 · shares: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.

SEC source: 0001410442-26-000002 · edgardoc.xml · derivative · entry 6

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,872 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: These securities are Restricted Stock Units.

F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

SEC source: 0001410442-26-000002 · edgardoc.xml · nonDerivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,833

F3 · security: These securities are Restricted Stock Units.

SEC source: 0001410442-26-000002 · edgardoc.xml · nonDerivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,526

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: These securities are Restricted Stock Units.